Loading
NexgenRx Inc. Stock: price and insider trades · Canada
NexgenRx Inc.: what insiders have been doing
Every trade that managers of NexgenRx Inc. disclose to SEDI is tracked on this page. The company sits in the Health Care sector. Between 24 October 2025 and 24 October 2026, 1 insider published 2 filings.
Every open-market trade in the period is a purchase: 1 purchase worth €4,366, from 1 insider, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €4,366, the purchase published on 27 July 2026 by Brennan, Linda is the largest of the period (0.017% of market cap). Among those who bought: 1 senior executive.
Compared with its exchange (2,734 companies, median 14 filings), a count of 2 filings is below the norm. Our records for NexgenRx Inc. go back to 2016, with 310 purchases and 5 sales on the open market in total.
The clock since the last published purchase (27 July 2026) now reads 89 days.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
334
Thresholds
n/a
Buy Volume
€10M
310 ops. · all time
Sell Volume
€27,857
5 ops. · all time
Who traded when
BuySaleLinda Brennan1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 4,114 of 26,290 companies
69.7
score / 100
Value56
Quality83
FCF yld11%
Earn yld2.5%
EV/EBITDA13.5x
ROE30%
Gross mgn83%
Net mgn5.9%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.60
Analyst consensus
Income statement
RevenueCA$17.9M
Gross profitCA$14.9M83% margin
EBITDACA$3.2M18% margin
Net incomeCA$1.1M13.6% margin
Valuation
PER (trailing)20.0x
P/Book5.5x
Beta0.46
Balance sheet & cash
Market capCA$42.7M
Total debtCA$365.6k
Free Cash FlowCA$4.6M
Debt / Equity3%
Profitability & ownership
ROE30.1%
ROA5.5%
% insiders37.0%
% institutions0.0%
Last declaration on 27 July 2026
Declarations334 total
10,000 shares@ CA$0.700.017% mcap100.0% of flowCommon SharesTSXSEDI:4756096
Canonical exit: 22 Oct 2026 (T+90)
Common SharesTSXSEDI:4756095
14,500 shares@ CA$0.24Common SharesTSXSEDI:4381930
Canonical exit: 30 Dec 2024 (T+90)
20,000 shares@ CA$0.250.3% of flowCommon SharesTSXSEDI:4376144
Canonical exit: 16 Dec 2024 (T+90)
15,000 shares@ CA$0.250.2% of flowCommon SharesTSXSEDI:4374868
Canonical exit: 12 Dec 2024 (T+90)
500 shares@ CA$0.24Common SharesTSXSEDI:4365451
Canonical exit: 20 Nov 2024 (T+90)
20,000 shares@ CA$0.250.3% of flowCommon SharesTSXSEDI:4361889
Canonical exit: 12 Nov 2024 (T+90)
5,000 shares@ CA$0.260.1% of flowCommon SharesTSXSEDI:4360294
Canonical exit: 5 Nov 2024 (T+90)
10,000 shares@ CA$0.260.2% of flowCommon SharesTSXSEDI:4358580
Canonical exit: 5 Nov 2024 (T+90)
13,500 shares@ CA$0.26Common SharesTSXSEDI:4355121
Canonical exit: 31 Oct 2024 (T+90)
10,000 shares@ CA$0.27Common SharesTSXSEDI:4355116
Canonical exit: 31 Oct 2024 (T+90)
30,000 shares@ CA$0.287.7% of flowCommon SharesTSXSEDI:4333613
77,500 shares@ CA$0.27519.4% of flowCommon SharesTSXSEDI:4333610
20,000 shares@ CA$0.285.1% of flowCommon SharesTSXSEDI:4333612
114,000 shares@ CA$0.27228.3% of flowCommon SharesTSXSEDI:4333611
Canonical exit: 15 Sept 2024 (T+90)
120,000 shares@ CA$0.2826.4% of flowCommon SharesTSXSEDI:4319771
Canonical exit: 22 Aug 2024 (T+90)
49,500 shares@ CA$0.281.0% of flowCommon SharesTSXSEDI:4318447
Canonical exit: 21 Aug 2024 (T+90)
14,000 shares@ CA$0.270.2% of flowCommon SharesTSXSEDI:4181975
Canonical exit: 10 Dec 2023 (T+90)
11,000 shares@ CA$0.27Common SharesTSXSEDI:4180478
Canonical exit: 6 Dec 2023 (T+90)
10,000 shares@ CA$0.27Common SharesTSXSEDI:4180474
Canonical exit: 6 Dec 2023 (T+90)
8,500 shares@ CA$0.332.8% of flowCommon SharesTSXSEDI:3932047
Canonical exit: 11 Jul 2022 (T+90)
10,000 shares@ CA$0.323.1% of flowCommon SharesTSXSEDI:3918214
Canonical exit: 29 Jun 2022 (T+90)
3,000 shares@ CA$0.360.4% of flowCommon SharesTSXSEDI:3844441
Canonical exit: 8 Mar 2022 (T+90)
3,000 shares@ CA$0.370.4% of flowCommon SharesTSXSEDI:3844442
Canonical exit: 8 Mar 2022 (T+90)
11,000 shares@ CA$0.371.4% of flowCommon SharesTSXSEDI:3842121
Canonical exit: 3 Mar 2022 (T+90)
25 of 334 declarations
About NexgenRx Inc.
NexgenRx Inc. is a Canadian company that provides healthcare management solutions and claims processing services. It focuses on technological innovation to enhance the efficiency of healthcare.
